Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 7, 2002, Pages 920-926

  Idell, Steven ^a,b,c,d,e   Mazar, Andrew ^a,b,c,d,e   Cines, Douglas ^a,b,c,d,e   Kuo, Alice ^a,b,c,d,e   Parry, Graham ^a,b,c,d,e   Gawlak, Susan ^a,b,c,d,e   Juarez, Jose ^a,b,c,d,e   Koenig, Kathy ^a,b,c,d,e   Azghani, Ali ^a,b,c,d,e   Hadden, Will ^a,b,c,d,e   McLarty, Jerry ^a,b,c,d,e   Miller, Edmund ^a,b,c,d,e  

^a UNIVERSITY OF TEXAS AT TYLER   (United States)

^b Attenuon LLC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e North Shore LIJ Research Institute ^*  (United States)

Author keywords

Fibrinolysis; Pleural scarring; Urokinase

Indexed keywords

DRUG VEHICLE; FIBRIN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROUROKINASE; TETRACYCLINE; UROKINASE RECEPTOR;

ADHESION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; EFFUSION; FEMALE; FIBRIN CLOT; FIBRINOLYSIS; HEMATOTHORAX; LUNG FIBROBLAST; MESOTHELIUM CELL; MORBIDITY; NONHUMAN; PLEURA FLUID; PLEURISY; PRIORITY JOURNAL; RABBIT;

ADHESIONS; ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; BODY FLUIDS; CELL COUNT; DISEASE MODELS, ANIMAL; EPITHELIUM; FEMALE; FIBRIN; FIBROBLASTS; PLEURA; PLEURAL EFFUSION; PLEURISY; RABBITS; RECEPTORS, CELL SURFACE; TETRACYCLINE; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036800197     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200204-313OC     Document Type: Article

References (31)

1. Sahn S. The pleura: state of the art. Am Rev Respir Dis 1988;138:184-234.
2. Light RW. Parapneumonic effusions: pleural diseases, 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 151-181.
3. Sahn SA. Pleural disease: pulmonary medicine and critical care MKSAP, 2nd ed. Philadelphia: American College of Physicians and American Society of Internal Medicine; 1998. p. 262-283.
4. Light RW. Hemothorax: pleural diseases, 4th ed. Philadelphia: Lippincott, Williams, and Wilkins; 2001. p. 320-326.
5. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations. J Clin Invest 1949;28:173-190.
6. Sahn SA. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax 1998;53:S65-S72.
7. Light RW, Rodriguez RM. Management of parapneumonic effusions. Clin Chest Med 1998;19:373-382.
8. Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, Sahn S, Weinstein RA, Yusen RD. Medical and surgical treatment of parapneumonic effusions: ACP consensus statement. Chest 2000;18:1158-1171.
9. Higazi AA, Mazar A, Wang J, Reilly R, Henkin J, Kniss D, Cines D. Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1. Blood 1996;87:3545-3549.
10. Higazi A. Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor. J Biol Chem 1995;270:17375-17380.
11. Manchanda N. Interaction of single-chain urokinase and plasminogen activator inhibitor type 1. J Biol Chem 1995;270:20032-20035.
12. Idell S, Girard W, Koenig KB, McLarty J, Fair DS. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 1991;144:187-194.
13. Shetty S, Idell S. A urokinase receptor mRNA binding protein from rabbit lung fibroblasts and mesothelial cells. Am J Physiol 1998;274:L871-L882.
14. Shetty S, Kumar A, Johnson AR, Pueblitz S, Holiday D, Raghu G, Idell S. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Am J Respir Cell Mol Biol 1996;15:78-87.
15. Idell S, Pendurthi U, Pueblitz S, Koenig K, Williams T, Rao LV. Tissue factor pathway inhibitor in tetracycline-induced pleuritis in rabbits. Thromb Haemost 1998;79:649-655.
16. Tarui T, Mazar AP, Cines DB, Takada Y. Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interactions. J Biol Chem 2001;276:3983-3990.
17. Higazi AA, Bdeir K, Hiss E, Arad S, Kuo A, Barghouti I, Cines DB. Lysis of plasma clots by urokinase soluble urokinase receptor complexes. Blood 1998;92:2075-2083.
18. Strange C, Baumann MH, Sahn SA, Idell S. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med 1995;151:508-515.
19. Mazar AP, Henkin J, Goldfarb RH. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 1999;3:15-32.
20. Miller EJ, Kajikawa O, Pueblitz S, Koenig KK, Idell S. Chemokine involvement in tetracycline-induced pleuritis. Eur Respir J 2000;14:1387-1393.
21. Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-1659.
22. Cameron R. Intrapleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2000;3:CD002312.
23. de Souza A, Offner PJ, Moore EE, Biffl WL, Haenel JB, Franciose RJ, Burch JM. Optimal management of complicated empyema. Am J Surg 2000;180:507-511.
24. Idell S. Extravascular coagulation and fibrin deposition in acute lung injury. New Horiz 1994;2:566-574.
25. Bdeir K, Muciano J-C, Tomaszewski J, Koniares L, Martinez J, Cines DB. Urokinase contributes to fibrinolysis in the pulmonary microcirculation. Blood 2000;96:1820-1826.
26. Perkins RS, Broaddus CV, Shetty S, Hamlton S, Idell S. Asbestos upregulates expression of the urokinase plasminogen activator receptor on mesothelial cells. Am J Respir Cell Mol Biol 1999;21:637-646.
27. Antony VB, Hott JW, Kunkel SL, Godbey SW, Burdick MD, Strieter RM. Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines. Am J Respir Cell Mol Biol 1995;12:581-588.
28. Idell S. Coagulation, fibrinolysis and fibrin deposition in lung injury and repair. In: Phan SH, Thrall RS, editors. Pulmonary fibrosis. New York: Marcel Dekker; 1995. p. 743-776.
29. Davies CWH, Lok S, Davies RJO. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med 1998;157:328-330.
30. Sahn SA. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax 1998;53:S65-S72.
31. Brott T, Bogousslavsky J. Treatment of acute ischemic stroke. N Engl J Med 2000;343:710-722.